Institutional investors purchased a net $376.1 thousand shares of RMD during the quarter ended March 2016 and now own 62.38% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BMO ASSET MANAGEMENT, INC. Bought 100.3 Thousand shares of ResMed Inc
FIRST QUADRANT LP Bought 97.1 Thousand shares of ResMed Inc